This study is not yet accepting patients
Tadalafil and Pembrolizumab in Recurrent or Metastatic Head and Neck Cancer
a study on Head and Neck Cancer Head and Neck Squamous Cell Carcinoma Squamous Cell Carcinoma Cancer, General Cancer of Esophagus Cancer, Metastatic Cancer of Mouth Cancer of Neck
Summary
- Eligibility
- for people ages 18 years and up (full criteria)
- Dates
- study startedestimated completion
- Principal Investigator
- Joseph Califano
Description
Summary
Official Title
Details
Keywords
Eligibility
Lead Scientist at UCSD
- Joseph Califano
Physician in Chief - Moores Cancer Center, Surgery. Authored (or co-authored) 351 research publications
Details
- Status
- not yet accepting patients
- Start Date
- Completion Date
- (estimated)
- Sponsor
- University of California, San Diego
- ID
- NCT03993353
- Phase
- Phase 2
- Study Type
- Interventional
- Last Updated